{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:08:21Z","timestamp":1792681701428,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0771-z","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T09:01:49Z","timestamp":1526547709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Apolipoprotein B\/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiaojiang","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panlin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinkai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"771_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000170146","volume":"12","author":"GA Kaysen","year":"1994","unstructured":"Kaysen GA. Hyperlipidemia of chronic renal failure. Blood Purif. 1994;12:60\u20137.","journal-title":"Blood Purif"},{"key":"771_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10157-013-0881-x","volume":"18","author":"K Ikewaki","year":"2014","unstructured":"Ikewaki K. In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease. Clin Exp Nephrol. 2014;18:261\u20134.","journal-title":"Clin Exp Nephrol"},{"key":"771_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ijcard.2017.06.105","volume":"248","author":"W Zhao","year":"2017","unstructured":"Zhao W, Zheng XL, Jiang ZN, Liao XB, Zhao SP. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy. Int J Cardiol. 2017;248:355\u201360.","journal-title":"Int J Cardiol"},{"key":"771_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2015.06.057","volume":"242","author":"R Quispe","year":"2015","unstructured":"Quispe R, Manalac RJ, Faridi KF, Blaha MJ, Toth PP, Kulkarni KR, Nasir K, Virani SS, Banach M, Blumenthal RS, Martin SS, Jones SR. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio to the remainder of the lipid profile: the very large database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015;242:243\u201350.","journal-title":"Atherosclerosis"},{"key":"771_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937\u201352.","journal-title":"Lancet"},{"key":"771_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0002-9149(96)00677-7","volume":"79","author":"AD Sniderman","year":"1997","unstructured":"Sniderman AD, Pedersen T, Kjekshus J. Putting low-density lipoproteins at center stage in atherogenesis. Am J Cardiol. 1997;79:64\u20137.","journal-title":"Am J Cardiol"},{"key":"771_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1463-1326.2007.00714.x","volume":"10","author":"M Andrikoula","year":"2008","unstructured":"Andrikoula M, McDowell IF. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab. 2008;10:271\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"771_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12944-015-0155-6","volume":"14","author":"Y Song","year":"2015","unstructured":"Song Y, Yang Y, Zhang J, Wang Y, He W, Zhang X, Zhu J, Lu Z. The apoB100\/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography. Lipids Health Dis. 2015;14:150.","journal-title":"Lipids Health Dis"},{"key":"771_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2215\/CJN.09830915","volume":"11","author":"Y Sato","year":"2016","unstructured":"Sato Y, Fujimoto S, Toida T, Nakagawa H, Yamashita Y, Iwakiri T, Fukuda A, Iwatsubo S. Apoprotein B\/Apoprotein a-1 ratio and mortality among prevalent dialysis patients. Clin J Am Soc Nephrol. 2016;11:840\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"key":"771_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/0886022X.2011.641515","volume":"34","author":"EC Samouilidou","year":"2012","unstructured":"Samouilidou EC, Karpouza AP, Kostopoulos V, Bakirtzi T, Pantelias K, Petras D, Tzanatou-Exarchou H, GE J. Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis. Ren Fail. 2012;34:160\u20134.","journal-title":"Ren Fail"},{"key":"771_CR11","doi-asserted-by":"publisher","first-page":"e1363","DOI":"10.1161\/JAHA.114.001363","volume":"3","author":"DC Wheeler","year":"2014","unstructured":"Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drueke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation of Cinacalcet HCl therapy to lower CardioVascular events (EVOLVE) trial. J Am Heart Assoc. 2014;3:e1363.","journal-title":"J Am Heart Assoc"},{"key":"771_CR12","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","volume":"358","author":"G Walldius","year":"2001","unstructured":"Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026\u201333.","journal-title":"Lancet"},{"key":"771_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ahj.2004.03.021","volume":"148","author":"K Dunder","year":"2004","unstructured":"Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B\/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala longitudinal study of adult men (ULSAM). Am Heart J. 2004;148:596\u2013601.","journal-title":"Am Heart J"},{"key":"771_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2796.2005.01610.x","volume":"259","author":"G Walldius","year":"2006","unstructured":"Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apoB\/apoA-I ratio: results of the AMORIS prospective study. J Intern Med. 2006;259:259\u201366.","journal-title":"J Intern Med"},{"key":"771_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","volume":"259","author":"G Walldius","year":"2006","unstructured":"Walldius G, Jungner I. The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence. J Intern Med. 2006;259:493\u2013519.","journal-title":"J Intern Med"},{"key":"771_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cjca.2017.08.004","volume":"33","author":"YM Zhu","year":"2017","unstructured":"Zhu YM, Verma S, Fung M, McQueen MJ, Anderson TJ, Lonn EM. Association of apolipoproteins b and a-1 with markers of vascular health or cardiovascular events. Can J Cardiol. 2017;33:1305\u201311.","journal-title":"Can J Cardiol"},{"key":"771_CR17","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL. 2016 ESC\/EAS guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37:2999\u20133058.","journal-title":"Eur Heart J"},{"key":"771_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2796.2006.01644.x","volume":"259","author":"A Thompson","year":"2006","unstructured":"Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B\/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med. 2006;259:481\u201392.","journal-title":"J Intern Med"},{"key":"771_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1681\/ASN.2013080816","volume":"26","author":"G Silbernagel","year":"2015","unstructured":"Silbernagel G, Genser B, Drechsler C, Scharnagl H, Grammer TB, Stojakovic T, Krane V, Ritz E, Wanner C, Marz W. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. J Am Soc Nephrol. 2015;26:484\u201392.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"771_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00059-014-4147-5","volume":"40","author":"P Liting","year":"2015","unstructured":"Liting P, Guoping L, Zhenyue C. Apolipoprotein B\/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients. Herz. 2015;40(Suppl 1):1\u20137.","journal-title":"Herz"},{"key":"771_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2004.10.017","volume":"179","author":"A Simon","year":"2005","unstructured":"Simon A, Chironi G, Gariepy J, Del PM, Levenson J. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis. 2005;179:339\u201344.","journal-title":"Atherosclerosis"},{"key":"771_CR22","doi-asserted-by":"publisher","first-page":"e54628","DOI":"10.1371\/journal.pone.0054628","volume":"8","author":"F Huang","year":"2013","unstructured":"Huang F, Yang Z, Xu B, Bi Y, Xu M, Xu Y, Lu J, Liu Y, Dai M, Zhou W, Wang W, Chen Y. Both serum apolipoprotein B and the apolipoprotein B\/apolipoprotein A-I ratio are associated with carotid intima-media thickness. PLoS One. 2013;8:e54628.","journal-title":"PLoS One"},{"key":"771_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1464-5491.2009.02693.x","volume":"26","author":"EM Dahlen","year":"2009","unstructured":"Dahlen EM, Lanne T, Engvall J, Lindstrom T, Grodzinsky E, Nystrom FH, Ostgren CJ. Carotid intima-media thickness and apolipoprotein B\/apolipoprotein A-I ratio in middle-aged patients with type 2 diabetes. Diabet Med. 2009;26:384\u201390.","journal-title":"Diabet Med"},{"key":"771_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.5551\/jat.16824","volume":"20","author":"T Emoto","year":"2013","unstructured":"Emoto T, Sawada T, Morimoto N, Tenjin T, Wakimoto T, Ikeda F, Sato C, Terashita D, Mizoguchi T, Mizuguchi T, Okamoto H, Matsuo Y, Kim SK, Takarada A, Yokoyama M. The apolipoprotein B\/A1 ratio is associated with reactive oxygen metabolites and endothelial dysfunction in statin-treated patients with coronary artery disease. J Atheroscler Thromb. 2013;20:623\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"771_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.atherosclerosis.2007.01.017","volume":"196","author":"C Schmidt","year":"2008","unstructured":"Schmidt C, Fagerberg B. ApoB\/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis. 2008;196:817\u201322.","journal-title":"Atherosclerosis"},{"key":"771_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jacl.2017.07.001","volume":"11","author":"BT Steffen","year":"2017","unstructured":"Steffen BT, Guan W, Remaley AT, Stein JH, Tattersall MC, Kaufman J, Tsai MY. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of multi-ethnic study of atherosclerosis participants. J Clin Lipidol. 2017;11:1181\u201391.","journal-title":"J Clin Lipidol"},{"key":"771_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-146-9-200705010-00007","volume":"146","author":"WA van der Steeg","year":"2007","unstructured":"van der Steeg WA, Boekholdt SM, Stein EA, El-Harchaoui K, Stroes ES, Sandhu MS, Wareham NJ, Jukema JW, Luben R, Zwinderman AH, Kastelein JJ, Khaw KT. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med. 2007;146:640\u20138.","journal-title":"Ann Intern Med"},{"key":"771_CR28","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","volume":"62","author":"JJ Albers","year":"2013","unstructured":"Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PJ, Xu P, Marcovina SM. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis intervention in metabolic syndrome with low HDL\/high triglyceride and impact on Global Health outcomes). J Am Coll Cardiol. 2013;62:1575\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"771_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2796.2010.02323.x","volume":"269","author":"PJ Kappelle","year":"2011","unstructured":"Kappelle PJ, Gansevoort RT, Hillege JL, Wolffenbuttel BH, Dullaart RP. Apolipoprotein B\/A-I and total cholesterol\/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein. J Intern Med. 2011;269:232\u201342.","journal-title":"J Intern Med"},{"key":"771_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/eurheartj\/ehn347","volume":"30","author":"J Sierra-Johnson","year":"2009","unstructured":"Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J, Walldius G, Hellenius ML, Hamsten A. Concentration of apolipoprotein B is comparable with the apolipoprotein B\/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J. 2009;30:710\u20137.","journal-title":"Eur Heart J"},{"key":"771_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1365-2796.2009.02074.x","volume":"265","author":"M Chmielewski","year":"2009","unstructured":"Chmielewski M, Carrero JJ, Qureshi AR, Axelsson J, Heimburger O, Berglund L, Barany P, Rutkowski B, Lindholm B, Stenvinkel P. Temporal discrepancies in the association between the apoB\/apoA-I ratio and mortality in incident dialysis patients. J Intern Med. 2009;265:708\u201316.","journal-title":"J Intern Med"},{"key":"771_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1525-139X.2006.00117.x","volume":"19","author":"J Liu","year":"2006","unstructured":"Liu J, Rosner MH. Lipid abnormalities associated with end-stage renal disease. Semin Dial. 2006;19:32\u201340.","journal-title":"Semin Dial"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0771-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:07:13Z","timestamp":1558033633000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0771-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["771"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0771-z","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"17 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of The First Affiliated Hospital of Nanchang University. It was conducted according to the standards of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"117"}}